Bristol-Myers Squibb Company

09/17/2021 | Press release | Distributed by Public on 09/17/2021 05:02

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal[...]